AzTrials
AzTrials

Tooth LossNCT02513602

Osseointegrated Dental Implants in Kidney Transplanted Patients

An observational study of Tooth Loss and Disorder Related to Renal Transplantation, run by University of Trieste at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The evaluation of the bone, using several techniques and on several aspects will be the purpose to study the possible impact of the kidney transplant (and, extensively, the pre-transplant dialysis, the organ replacement and the immunosuppressive therapy) could have on the bone metabolism and on the density of the bone… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Dental implant insertion
Type of treatment
Surgery or procedure
How many people
26 participants
Where
1 siteItaly
Study dates
May 2014to Aug 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The minimal number of the participants of this study is 26 per group: this results from the measure of a 0,8 effect size. If the effect size is less than 1 (minimal value), it represents the situation where the medium difference of standard deviations of the variable "bone density" is equivalent to the difference of the value between the two groups of the study. Subject of test group will be enrolled an a kidney transplanted patients, while Subjects of control group will be enrolled retrospectively in healthy patients

Who may be able to join

  • Diagnosis: single or partial mandibular molar-premolar edentulism that requires up to 2 fixtures
  • Good systemic compensation of the kidney transplant (≤ ASA American Society of Anesthesiologists score 3) with at least 1 year of previous hemodialysis or peritoneal dialysis and in actual immunosuppressive therapy
  • Be older than 18 years
  • The patient must be able to understand the meaning of the study and accept to undergo periodical follow-up controls.
  • The patient must be able to understand and practice all the oral hygiene procedures demanded by the experimenter
  • Signature of the informed consent form
Show all 11Show fewer
  • and for control
  • Diagnosis: single or partial mandibular molar-premolar edentulism that requires up to 2 fixtures
  • Having a pre-operatory cone beam CT available
  • Age older than 18 years
  • Signature of the authorization to use and process personal details at the acceptance of every sort of treatment in the Company Hospital of Trieste.

Who cannot join

  • Post extraction implant (before 3 months from the extraction)
  • Be less than 18 years old
  • Smoking more than 10 cigarettes/day
  • Plaque index more than 25
  • Bleeding on probe index more than 25
  • Clear allergy or intolerance against the products used in the study
Show all 10Show fewer
  • Patients that require reconstructive bone surgery before the fixtures placement (gbr and bone grafting)
  • and for control group
  • Patients that require reconstructive bone surgery before the fixtures placement (gbr and bone grafting)
  • Pathologies and pharmacological therapies that interfere with bone (for instance osteoporosis, osteomalacia, malnutrition, Paget's disease, corticosteroid therapy, bisphosphonate therapy, head and neck radiotherapy)

Trial locations and contacts

1 site in 1 country.

Federico Berton, DDS contact

0403992254 ext. 0039

fberton@units.it

Italy1 site, 1 recruiting
  • University Hospital Company, "Ospadale Maggiore"

    Trieste, TS, 34100

    Federico Berton, DDS, 0403992254 ext. 0039, fberton@units.it

    Gaetano Castronovo, MS, Msc, 0403992254 ext. 0039, gaetanoca@tiscali.it

    Recruiting

Other trials in Italy

About this study

Official title: Peri-Implant Bone Assessment in Transplanted Patients: A Case Control Study

The evaluation of the bone, using several techniques and on several aspects will be the purpose to study the possible impact of the kidney transplant (and, extensively, the pre-transplant dialysis, the organ replacement and the immunosuppressive therapy) could have on the bone metabolism and on the density of the bone where the implants are placed. The assessment on the bone density only in a retrospectively selected population that underwent the same surgical procedure will help the comparison of the data to get a satisfactory conclusion. The evaluation of other clinical and instrumental parameters in the test group makes the kidney-transplant patients bone quality clear, and will consequently demonstrate if implants are a feasible therapy for these patients.

Read the detailed description

The primary purpose of this study is the evaluation of the effects of the kidney transplant on the periimplant bone density by the comparison with the density of healthy patients. The secondary purpose is obtaining clinical, histological and radiographic data to evaluate the effect of systemic conditions and its rebound on the insertion of fixtures.

Evaluation criteria

  1. Control group: evaluation of the periimplant bone density (1 mm) next to the implant virtually planned using the CT editing software on the cone beam CT acquired in a retrospective sample of patients already treated with the insertion of a fixture in the molar or premolar edentulous site
  2. Test group: periodontal evaluation with plaque index, bleeding on probing index and probing 1 month before operation.
  3. Test group: evaluation of periimplant bone density (1 mm) in the fixture virtual-projected zone (the implant will be inserted there) with the CT acquisition and editing software.
  4. Test group: evaluation of the implant stability after their insertion (primary stability) using the Resonance Frequence Analysis. ISQ (Implant Stability Quotient) value is expressed in 4 numbers (mesial, distal, buccal, lingual), average values of three measures acquired in each side.
  5. Test group: evaluation of the implant stability immediately after the insertion calculating the insertional torque value (ITV) with an implant motor.
  6. Test group: evaluation of the periimplant bone using an endoral periapical radiograph with Rinn device immediately after the operation.
  7. Test group: histomorphological examination of the bone core sample made by a trephine resulted from the implant site preparation
Being tested
Dental implant insertion
Keywords
implantology, kidney, renal disease, edentulism, tooth loss
Medical subject headings
Tooth Loss, Kidney Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dental implant insertionProcedure or surgery

    Dental implant insertion will be carry out in the mandible of the patients enrolled, through a surgical template in order to repeat the same position of the simulating implant insertion. After a trephine bur passage, the final two or three twist-drills will be used to realize the implant socket. After implant positioning, a cover screw will be tightened and the mucosa sutured above.

Study groups in NCT02513602
Study groupRoleWhat they receive
TEST group (kidney transplanted)Kidney transplanted patients, passed through dialysis phase presenting a mandibular edentulism. It will be scheduled one or two dental implants to be inserted in mandible. This group will be subjected to a dental implant insertion procedure.
Receives: Procedure: Dental implant insertion
CONTROL group (healthy patients)Healthy patients, with an inserted mandibular implant, retrospectively enrolled with a preoperative cbct scan.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bone density measured in Grey Value

    bone density will be assessed on the cone beam CT scans with the virtual implant positioning before surgery (for the test group) and postoperatively (retrospectively assessed) for the control group. Grey Value will be assessed in the area of 1 mm around the shape of the implants.

    Measured: seven days after cone beam computed tomography

Secondary outcomes (2)
  1. Insertional torque value

    Only for the test group the Insertional torque value will be assessed during surgery.

    Measured: during implant placement

  2. Histomorphometric analysis

    Only for the test group the microscopic analysis will be performed on the specimen harvested during surgery (via trephine bur, preparing the implant site)

    Measured: within 20 days after implant placement

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jul 2015 (estimated)
  2. Study startMay 2014
  3. Primary completionMay 2020 (estimated)
  4. Study completionAug 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
26 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02513602
Sponsor's protocol ID
ITR
Status last verified
Nov 2016
First submitted
20 Jul 2015
Last updated
2 Nov 2016
Results posted
No
Data monitoring committee
Yes

Publications

  • Arisan V, Karabuda ZC, Avsever H, Ozdemir T. Conventional multi-slice computed tomography (CT) and cone-beam CT (CBCT) for computer-assisted implant placement. Part I: relationship of radiographic gray density and implant stability. Clin Implant Dent Relat Res. 2013 Dec;15(6):893-906. doi: 10.1111/j.1708-8208.2011.00436.x. Epub 2012 Jan 17.

    PubMed 22251553
  • Cassetta M, Stefanelli LV, Di Carlo S, Pompa G, Barbato E. The accuracy of CBCT in measuring jaws bone density. Eur Rev Med Pharmacol Sci. 2012 Oct;16(10):1425-9.

    PubMed 23104660
  • Zou H, Zhao X, Sun N, Zhang S, Sato T, Yu H, Chen Q, Weber HP, Dard M, Yuan Q, Lanske B. Effect of chronic kidney disease on the healing of titanium implants. Bone. 2013 Oct;56(2):410-5. doi: 10.1016/j.bone.2013.07.014. Epub 2013 Jul 19.

    PubMed 23876979

Questions about this trial

What is this clinical trial studying?

An observational study of Tooth Loss and Disorder Related to Renal Transplantation, run by University of Trieste at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Federico Berton, DDS (0403992254 ext. 0039, fberton@units.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bone density measured in Grey Value (time frame: seven days after cone beam computed tomography). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02513602, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in